EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Validating meropenem forecasts for the next dose during CRRT

Yu Jiang iD, Ruisi Chen, Peng Li iD

Antimicrobial Agents and Chemotherapy · 10.11.2026

DOI: 10.1128/aac.01271-26 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 10.11.2026. Verfasst von Yu Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Bayesian forecastingcontinuous renal replacement therapymeropenemmodel-informed precision dosingtherapeutic drug monitoring

Autor:innen und Institutionen

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

ORCID-Profile: Yu Jiang, Peng Li

Zitieren

APA

Jiang, Y., Chen, R., & Li, P. (2026). Validating meropenem forecasts for the next dose during CRRT. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01271-26

Vancouver

Jiang Y, Chen R, Li P. Validating meropenem forecasts for the next dose during CRRT. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01271-26

BibTeX
@article{Jiang2026,
  author = {Jiang, Yu and Chen, Ruisi and Li, Peng},
  title = {Validating meropenem forecasts for the next dose during CRRT},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01271-26}
}
Kostenlos starten →